Advertisement
Canada markets close in 6 hours 4 minutes
  • S&P/TSX

    21,674.81
    +86.93 (+0.40%)
     
  • S&P 500

    5,484.17
    +10.94 (+0.20%)
     
  • DOW

    38,873.52
    +95.42 (+0.25%)
     
  • CAD/USD

    0.7290
    +0.0001 (+0.02%)
     
  • CRUDE OIL

    80.78
    +0.45 (+0.56%)
     
  • Bitcoin CAD

    88,843.56
    -580.73 (-0.65%)
     
  • CMC Crypto 200

    1,345.26
    -44.15 (-3.18%)
     
  • GOLD FUTURES

    2,334.60
    +5.60 (+0.24%)
     
  • RUSSELL 2000

    2,024.69
    +2.69 (+0.13%)
     
  • 10-Yr Bond

    4.2520
    -0.0270 (-0.63%)
     
  • NASDAQ

    17,849.75
    -7.27 (-0.04%)
     
  • VOLATILITY

    12.41
    -0.34 (-2.67%)
     
  • FTSE

    8,196.30
    +54.15 (+0.67%)
     
  • NIKKEI 225

    38,482.11
    +379.67 (+1.00%)
     
  • CAD/EUR

    0.6780
    -0.0007 (-0.10%)
     

Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

AUSTIN, Texas, June 03, 2024--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 7:40 a.m. PT (10:40 a.m. ET).

A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

ADVERTISEMENT

View source version on businesswire.com: https://www.businesswire.com/news/home/20240603615720/en/

Contacts

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com
Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com